O-150 A phase II study of SGN-15 (cBR96-doxorubicin immunoconjugate) combined with docetaxel in patients with advanced stage or metastatic non-small cell lung cancer (NSCLC)
Ross, Helen, Rudin, Charles M., Figlin, Robert A., Hart, Lowell, Rarick, Mark, Jacobs, Andrew, Grove, Laurie, Sandler, Andrew S., Siegall, Clay, Sing, Amy P.Volume:
41
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)91808-3
Date:
August, 2003
File:
PDF, 188 KB
english, 2003